Abstract
Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 546-550 |
| Numero di pagine | 5 |
| Rivista | The Lancet Diabetes and Endocrinology |
| Volume | 8 |
| Numero di pubblicazione | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Medicina Interna
- Endocrinologia, Diabete e Metabolismo
- Endocrinologia
Keywords
- Betacoronavirus
- COVID-19
- Comorbidity
- Contraindications
- Coronavirus Infections
- Diabetes Mellitus
- Drug
- Humans
- Hypoglycemic Agents
- Multiple Organ Failure
- Pandemics
- Pneumonia
- Practice Guidelines as Topic
- Respiratory Distress Syndrome
- SARS-CoV-2
- Type 1
- Type 2
- Viral
Fingerprint
Entra nei temi di ricerca di 'Practical recommendations for the management of diabetes in patients with COVID-19'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver